Attached files
| file | filename |
|---|---|
| EX-31.2 - EX-31.2 - Longboard Pharmaceuticals, Inc. | lbph-20210331-ex31_2.htm |
| EX-31.1 - EX-31.1 - Longboard Pharmaceuticals, Inc. | lbph-20210331-ex31_1.htm |
| EX-3.2 - EX-3.2 - Longboard Pharmaceuticals, Inc. | lbph-20210331-ex3_2.htm |
| EX-3.1 - EX-3.1 - Longboard Pharmaceuticals, Inc. | lbph-20210331-ex3_1.htm |
| 10-Q - 10-Q - Longboard Pharmaceuticals, Inc. | lbph-20210331.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Longboard Pharmaceuticals, Inc. (the “Company”) on Form 10-Q for the three months ended March 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
1.
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
2.
The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
Date: May 10, 2021 |
|
By: |
/s/ Kevin R. Lind |
|
|
|
Kevin R. Lind |
|
|
|
President and Chief Executive Officer |
|
|
|
(Principal Executive Officer) |
Date: May 10, 2021 |
|
By: |
/s/ Brandi L. Roberts |
|
|
|
Brandi L. Roberts |
|
|
|
Chief Financial Officer |
|
|
|
(Principal Financial and Accounting Officer) |